Search

Author/Creator Ducore, J.

1. Immunogenicity, efficacy and safety of Nuwiq® (human‐cl rhFVIII) in previously untreated patients with severe haemophilia A—Interim results from the NuProtect Study. Issue 2 (16th August 2017)

Authors:
Liesner, R. J.; Abashidze, M.; Aleinikova, O.; Altisent, C.; Belletrutti, M. J.; Borel‐Derlon, A.; Carcao, M.; Chambost, H.; Chan, A. K. C.; Dubey, L.; Ducore, J.; Fouzia, N. A.; Gattens, M.; Gruel, Y.; Guillet, B.; Kavardakova, N.; El Khorassani, M.; Klukowska, A.; Lambert, T.; Lohade, S.
Journal:
Haemophilia
Issue:
Volume 24:Issue 2(2018)
Page Start:
211
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Safety and dose‐dependency of eptacog beta (activated) in a dose escalation study of non‐bleeding congenital haemophilia A or B patients, with or without inhibitors. Issue 6 (5th October 2017)

Authors:
Ducore, J.; Lawrence, J. B.; Simpson, M.; Boggio, L.; Bellon, A.; Burggraaf, J.; Stevens, J.; Moerland, M.; Frieling, J.; Reijers, J.; Wang, M.
Journal:
Haemophilia
Issue:
Volume 23:Issue 6(2017)
Page Start:
844
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search